Abstract
We have evaluated 169 patients with portal hypertension receiving endoscopic variceal sclerotherapy in order to assess the predisposing factors, clinical profile, and treatment response of sclerotherapy-induced esophageal strictures. Of the 129 patients included in the final analysis, 20 (15.5%) developed persistent esophageal stricture. No significant difference was found with respect to age, nature of sclerosant (absolute alcohol, ethanolamine oleate, or sodium tetradecyl sulfate), etiology of portal hypertension, Child's class, initial variceal score, or intensity of sclerotherapy schedule between the patients who developed strictures and those who did not. However, female sex (P<0.01) and persistent esophageal ulceration (P<0.05) did predispose to stricture formation. Sclerotherapy-induced strictures presented with a variable grade of dysphagia, were always solitary, and were localized to the lower end of esophagus. Most of these could be dilated rapidly using Eder-Puestow metal olives (3.15±0.80 dilatation sessions per patient). Stricture formation did interrupt an effective sclerotherapy program but only temporarily, and successful variceal obliteration could be obtained after stricture dilatation.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Sorensen T, Burcharth F, Pedersen ML, Findahl F: Oesophageal stricture and dysphagia after endoscopic sclerotherapy for bleeding varices. Gut 25:473–477, 1984
Kitano S, Iso Y, Yamaga H, Hashizume M, Higashi H, Sugimachi K: Trial of sclerosing agents in patients with oesophageal varices. Br J Surg 75:751–753, 1988
Korula J, Balart LA, Radvan G, Zweiban BE, Larson AW, Kao HW, Yamada S: A prospective, randomised controlled trial of chronic esophageal variceal sclerotherapy. Hepatology 4:584–589, 1985
Howard ER, Stringer MD, Mowat AP: Assessment of injection sclerotherapy in the management of 152 children with oesophageal varices. Br J Surg 75:404–408, 1988
Sarin SK, Mishra SP, Sachdev GK, Thorat V, Dalal L, Broor SL: Ethanolamine oleate versus absolute alcohol as a variceal sclerosant: A prospective, randomized, controlled trial. Am J Gastroenterol 83:526–530, 1988
Haynes WC, Sanowski RA, Foutch PG, Bellapravalu S: Esophageal strictures following endoscopic variceal sclerotherapy: Clinical course and response to dilatation therapy. Gastrointest Endosc 32:202–205, 1986
Akriviadis E, Korula J, Gupta S, Ko Y, Yamada S: Frequent endoscopic variceal sclerotherapy increases risk of complications. Prospective randomized controlled study of two treatment schedules. Dig Dis Sci 34:1068–1074, 1989
Rose JDR, Crane MD, Smith PM: Factors affecting successful endoscopic sclerotherapy for oesophageal varices. Gut 24:946–949, 1983
Sarin SK, Nanda R, Sachdev G, Chari S, Anand BS, Broor SL: Intravariceal versus paravariceal sclerotherapy—a prospective, controlled, randomised trial. Gut 28:657–662, 1987
Snady H, Rosman AS, Korsten MA: Prevention of stricture formation after endoscopic sclerotherapy of esophageal varices. Gastrointest Endosc 35:377–380, 1989
Drell E, Prindiville T, Trudeau W: Post-sclerotherapy stricture: Etiology, incidence and therapy. Gastrointest Endosc 31:138, 1985 (abstract)
MacDougall BRD, Westaby D, Theodossi A, Dawson JL, Williams R: Increased long-term survival in variceal haemorrhage using injection sclerotherapy. Lancet 1:124–127, 1982
Sarin SK, Sachdev G, Nanda R, Batra SK, Anand BS: Comparison of the two time schedules for endoscopic sclerotherapy—a prospective randomized controlled study. Gut 27:710–713, 1986
Pugh RNH, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R: Transection of oesophagus for bleeding oesophageal varices. Br J Surg 60:646–649, 1973
Conn HO: Ammonia tolerance in the diagnosis of oesophageal varices. A comparison of endoscopic, radiological and biochemical techniques. J Lab Clin Med 70:442–451, 1967
Kochhar R, Goenka MK, Mehta S, Mehta SK: A comparative evaluation sclerosants for esophageal varices: A prospective randomised controlled study. Gastrointest Endosc 36:127–130, 1990
Kahn D, Terblanche J, Kitano S, Borman P: Injection sclerotherapy in adult patients with extrahepatic portal venous obstruction. Br J Surg 74:600–602, 1987
Bhargava DK, Dwivedi M, Dasarathy S, Arora A: Endoscopic sclerotherapy for portal hypertension due to extrahepatic obstruction: Long term follow up. Gastrointest Endosc 35:309–311, 1989
Bhargava DK, Dwivedi M, Dasarathy S, Sundaram KR: Sclerotherapy after variceal hemorrhage in noncirrhotic portal fibrosis. Am J Gastroenterol 84:1235–1238, 1989
El-Zayadi A, El-Din SS, Kabil SM: Endoscopic sclerotherapy versus medical treatment for bleeding esophageal varices in patients with schistosomal liver disease. Gastrointest Endosc 34:314–317, 1988
Sarin SK, Nanda R, Vij JC, Anand BS: Esophageal ulceration after sclerotherapy—a complication or accompaniment? Endoscopy 18:44–45, 1986
Roark G: Treatment of post-sclerotherapy esophageal ulcers with sucralfate. Gastrointest Endosc 30:9–10, 1984
Tabibian N, Smith JL, Graham DY: Sclerotherapy associated esophageal ulcers: Lessons from a double blind, randomized comparison of sucralfate suspension versus placebo. Gastrointest Endosc 35:312–315, 1989
Singal AK, Sarin SK, Misra SP, Broor SL: Ulceration after esophageal and gastric variceal sclerotherapy—Influence of sucralfate and other factors on healing. Endoscopy 20:238–240, 1988
Larson GM, Vandertoll DJ, Netscher DT, Polk HC: Esophageal motility: Effects of injection sclerotherapy. Surgery 96:703–710, 1984
Author information
Authors and Affiliations
Additional information
Reprints not available.
Rights and permissions
About this article
Cite this article
Kochhar, R., Goenka, M.K. & Mehta, S.K. Esophageal strictures following endoscopic variceal sclerotherapy. Digest Dis Sci 37, 347–352 (1992). https://doi.org/10.1007/BF01307726
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01307726